| Name | Cel AI |
|---|---|
| Epic | CLAI |
| Isin | GB00BK964W87 |
| Industry | Pharmaceuticals & Biotechnology |
| Latest share price | 0.05p | Net gearing | n/a |
|---|---|---|---|
| Market capitalisation | £0.31 | Debt ratio | n/a |
| Shares in issue | 602.25 | Debt-to-equity ratio | n/a |
| P/E ratio | n/a | Assets / equity ratio | n/a |
| Total dividends per share | n/a | Price to book value | n/a |
| Dividend yield | n/a | ROCE | -147.33 |
| Dividend cover | n/a | EPS growth | n/a |
| Earning per share | -0.61 | 52-week high / low | 0.05p / 0.60p |
| Type | Ex-date | Pay-date | Net-dividend |
|---|---|---|---|
| No dividends declared | |||
| Company name | Cel AI |
|---|---|
| Address | 16, Great Queen Street, London, United Kingdom, WC2B 5DG |
| Telephone | +44 (0)20 7031 6871 |
| Website | http://www.getcel.ai |
| Director | Position |
|---|---|
| Mr Bruna Nikolla | CFO |
| Mr Matthew Lodge | Non-Executive Director |
| Mr Misha Sher | Non-Executive Director |
| Mr Michael Edwards | Executive Director |
| Assets £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Reporting date | 31/08/23 | 31/08/22 | 31/08/21 |
| Intangible asssets and goodwill | n/a | n/a | n/a |
| Investments and other non-current assets | n/a | n/a | n/a |
| Total non-current assets | n/a | n/a | n/a |
| Inventory / work in progress | 0.58 | 0.5 | 0.06 |
| Trade and other receivables | 0.09 | 0.25 | 0.36 |
| Cash and equivalents | 1.77 | 4.38 | 10.33 |
| Other current assets and asset held for resale | n/a | n/a | n/a |
| Total of all assets | 2.45 | 5.13 | 10.75 |
| Liabilities £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Short term liabilities | 0.19 | 0.28 | 0.2 |
| Long term liabilities | n/a | n/a | n/a |
| Other liabilites / pension etc | n/a | n/a | n/a |
| Total of all liabilities | 0.19 | 0.28 | 0.2 |
| Net assets £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Net assets | 2.26 | 4.85 | 10.55 |
| Equity £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Share capital | 0.6 | 0.51 | 0.5 |
| Minority interests | n/a | n/a | n/a |
| Retained earnings | -13.04 | -9.73 | -3.74 |
| Share premium account | 12.99 | 12.51 | 12.49 |
| Total equity | 2.26 | 4.85 | 10.55 |
| Income £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Turnover | n/a | n/a | n/a |
| Operating profit | -3.33 | -5.99 | -3.33 |
| Pre-tax profit | -3.31 | -5.99 | -3.33 |